Portfolio Watch: Fiscal prudence is hot again; demand for homes slowing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Portfolio Watch: Hot August for inflation; End of the pandemic real estate boom?
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Limoneira beats earnings estimates for Q3, Mission Produce falls short
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Portfolio Watch: Bank of the West sees more rate hikes on the horizon
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne wins $596M space station contract
Thousand Oaks-based Teledyne won a NASA contract worth as much as $596 million, the company announced Sept. 8. In a news release, Teledyne, a technology and defense conglomerate, said its subsidiary, Teledyne Brown Engineering, was awarded the Marshall Operations, Systems, Services and Integration II (MOSSI II) contract for the International Space Station. It has a Read More →
AeroVironment shares soar 15% after earnings report
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Revenue and losses both up at Cure Pharmaceutical
Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, reported more losses but rising revenue in its second quarter earnings. Cure suffered a net loss of $9.6 million in the second quarter of 2022, up substantially from a net loss of $1.3 million in the same quarter a year ago. That equates to Read More →
